- Home
- RCUS vs RSI Comparison
RCUS vs RSI Comparison
Compare RCUS & RSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | RSI |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RCUS | RSI |
|---|---|---|
| Price | $24.31 | $29.09 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 10 |
| Target Price | ★ $31.90 | $28.20 |
| AVG Volume (30 Days) | 1.0M | ★ 2.2M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 933.33 |
| EPS | N/A | ★ 0.08 |
| Revenue | $247,000,000.00 | ★ $1,134,428,000.00 |
| Revenue This Year | N/A | $25.44 |
| Revenue Next Year | $45.62 | $14.27 |
| P/E Ratio | ★ N/A | $363.63 |
| Revenue Growth | N/A | ★ 22.76 |
| 52 Week Low | $7.92 | $13.43 |
| 52 Week High | $28.72 | $30.96 |
Technical Indicators
Market Signals| Indicator | RCUS | RSI |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 60.70 |
| Support Level | $23.91 | $26.00 |
| Resistance Level | $24.33 | N/A |
| Average True Range (ATR) | 1.45 | 1.12 |
| MACD | 0.04 | 0.16 |
| Stochastic Oscillator | 57.31 | 70.32 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About RSI Rush Street Interactive Inc.
Rush Street Interactive Inc is an online gaming and entertainment company that focuses on online casinos and online sports betting in the U.S. and Latin American markets. It provides customers with an array of gaming offerings such as real-money online casinos, online sports betting, and retail sports betting, as well as social gaming, which involves free-to-play games that use virtual credits that can be earned or purchased. The company generates revenue by offering online casinos, online sports betting, and social gaming directly to the end customer through its websites or apps. The company generates revenue through business-to-consumer (B2C) and business-to-business (B2B) models.